‘Bonus’ effect under EPO practice
The concept of a ‘bonus’ effect refers to a situation where inventive step is denied despite the presence of an unexpected technical effect. Although relatively rare, it has been applied in a number of decisions of the Boards of Appeal. Read more in the latest blog post.
More guidance on applying G 2/21 - T 1950/23
T 1950/23 is a further decision applying the principles of G 2/21, addressing the assessment of compliance with its requirements and the circumstances in which post-published data may be relied upon in the evaluation of inventive step. Read more in the latest article.
Non-reproducible commercial products and inventive step – T 1044/23
In T 1044/23, the Technical Board of Appeal of the EPO applied the principles of G 1/23 in the context of inventive step. Read more in our latest blog post.
Webinar on EPO practice: G 2/21 and Inventive Step – Reliance on a Purported Technical Effect
In this on-demand webinar, we review selected decisions applying G 2/21 and share key takeaways for those working with European patent portfolios, particularly in the chemical and pharmaceutical sectors.
There’s an alternative, and then there’s an ‘alternative’ - T 1468/23
In T 1468/23, the EPO’s Board of Appeal overturned the reasoning of the Opposition Division on inventive step after reassessing the comparison between the claimed invention and the closest prior art. Read more in the latest blog post.